Plain-English translation of NCT05318196 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This is a long-term research study that tracks people with kidney disease or at risk for developing it. Researchers will collect blood and tissue samples along with medical information to understand the molecular and genetic patterns that predict who will develop kidney problems, how the disease will progress, and what complications might arise.
Kidney disease affects hundreds of millions of people worldwide and can lead to serious complications including infections, heart disease, and death. This study aims to find biological markers that can predict kidney disease earlier and help doctors prevent or slow its progression before serious damage occurs.
You likely qualify if…
You likely don't qualify if…
You will be followed for 10 years as part of your regular kidney disease care at the hospital. Blood and tissue samples will be collected at your first visit, at each of your scheduled routine appointments, and whenever you experience a health event like an infection or acute kidney problems. The study collects information about your medical condition and stores samples to analyze the biological patterns linked to kidney disease development and complications.
AI-generated summary from trial data · Jul 17, 2026 · Not medical advice
France
Sponsor
University Hospital, Toulouse
Enrollment target
~5,000 participants
Started
September 2022
Primary completion
September 2027
Age range
18 Years – 99 Years
Last updated on clinicaltrials.gov in March 2026.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Stanislas Faguer, MD, PhD
University Hospital, Toulouse
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.